(NASDAQ: XRAY) Dentsply Sirona's forecast annual revenue growth rate of 1.33% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.58%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.54%.
Dentsply Sirona's revenue in 2026 is $3,680,000,000.On average, 17 Wall Street analysts forecast XRAY's revenue for 2026 to be $728,685,566,784, with the lowest XRAY revenue forecast at $689,934,196,182, and the highest XRAY revenue forecast at $763,242,201,393. On average, 17 Wall Street analysts forecast XRAY's revenue for 2027 to be $743,866,516,092, with the lowest XRAY revenue forecast at $704,915,396,157, and the highest XRAY revenue forecast at $782,617,886,694.
In 2028, XRAY is forecast to generate $766,238,441,388 in revenue, with the lowest revenue forecast at $720,096,345,465 and the highest revenue forecast at $826,163,241,288.